Fire-service OTC · Adult & pediatric scope · FS-ARN

Poison oak / sumac products

10-second priorities

FS-ARN
Start here
FS-ARN program scope only; this is not a general ALS/BLS administration order.
Do not miss
Check known allergy and the exact product’s current label.
Next decision
No pediatric 9-1-1 regimen is supplied by SO-F-02.

Priority checkpoints. Full criteria, doses and exceptions below.

OTC poison oak and sumac product-category guidance under SO-F-02.

OCEMS source summary · Updated 2026-09-30

Safety sections checked September 30, 2026 · category-specific product label unresolved. Existing numeric regimens retain their original source context.

FIELD REFERENCE

Full criteria & treatment guidance

Indications

  • SO-F-02 lists this product/category for eligible firefighting personnel in the authorized FS-ARN role. Use is limited to the indications printed on the actual container; the policy does not identify one active-ingredient formulation.

Contraindications & local exclusions

  • SO-F-02 excludes known allergy to the specific medication. A complete formulation-specific contraindication list is not established for this category; identify the active ingredients and read the current product label before use.

Precautions

  • The category name does not establish dose, route, age eligibility or interactions. Follow the container label and FS-ARN program restrictions. No general pediatric or 9-1-1 authority is established by this listing.
  • These are selected safety checks, not a complete prescribing monograph. Product labeling and OCEMS authorization answer different questions; confirm the actual product, patient population and applicable order.

Scope & authority

  • FS-ARN scope only; this listing is not a general ALS/BLS administration order.
  • SO-F-02 supplies no pediatric field regimen.

Adult / adolescent

  • SO-F-02 permits an authorized Fire Service RN to maintain this listed OTC product/category while functioning in the fire-service role. It is made available to firefighting personnel without a known allergy to the product.
  • Use this medication only for the indications and doses printed on its container. OCEMS does not publish a universal dose for this product. Eligible personnel must obtain the medication from its container without assistance.

Pediatric

  • SO-F-02 applies to adult and adolescent fire-service personnel. It does not authorize pediatric 9-1-1 dosing, and this page does not add consumer pediatric doses.
  • Do not convert a package’s consumer pediatric directions into OCEMS field authority. Use an applicable pediatric standing order or medical direction for a child requiring care.

Pediatric dosing availability

  • SO-F-02 supplies no pediatric 9-1-1 dosing or administration authority. This page does not add consumer pediatric doses.
Pediatric dosing availability
WeightOCEMS pediatric dose
Any weightNo general OCEMS pediatric dose is listed; follow the applicable order or medical direction.

Use, monitoring & documentation

  • Identify the exact product, active ingredients, strength, and label before use; products in a named OTC category can have different formulations.
  • Follow the product’s labeled indications, exclusions, dose, and interval within the authorized program. The absence of an EMS numerical dose here is intentional: SO-F-02 delegates those details to the product label.

UNDERSTAND THE CARE

Product category and exposure assessment are different tasks

Identify the selected poison-oak or sumac product and its active ingredients and intended application. The broad category does not establish one universal drug or a complete contraindication list. Keep the assessment of the exposure and symptoms separate from choosing a package-labeled product. The linked OCEMS document establishes the program context; a product-specific label answers a different question about the selected preparation.

Teaching diagram: Program: Eligible FS-ARN setting and personnel.; Identity: Exact product, ingredients and formulation.; Label: Current directions, allergy and exclusions.; Record: Product and actual amount; no invented pediatric regimen.
Poison oak / sumac products assessment map. A teaching map of the linked guidance; it is not a complete treatment algorithm.

Applying the guidance

Confirm that the person and setting fit the FS-ARN program before using the supply listing. Then reconcile the container, ingredients, strength, route and label with the intended use and document what was actually used. If the exact product is not established, retain that uncertainty rather than filling the gap with a consumer dose from another formulation. The pediatric limitation remains explicit.

Diagram text & teaching checkpoints

Program
Eligible FS-ARN setting and personnel.
Identity
Exact product, ingredients and formulation.
Label
Current directions, allergy and exclusions.
Record
Product and actual amount; no invented pediatric regimen.

Sources for this explanation

Original OCMedic teaching synthesis of the references below. Educational expansion updated ; this is not a new independent clinical-review date. Source-specific dates and limitations remain in the full guidance.

About OCMedic · Editorial approach & corrections

Identify the preparation before interpreting the category

The county listing names a group of poison-oak and sumac preparations. It does not identify one active ingredient, concentration or method of use. Keep the actual package available and read the instructions for that product. A cleansing preparation and a symptom-relief product should not be treated as interchangeable merely because both mention poison oak.

For example, a responder brings a product from home and requests that the same directions be used for a differently named item in the kit. Check the actual labels rather than transferring the first product’s amount, application instructions or exclusions to the second. This page cannot supply those missing formulation details.

The SO-F-02 eligibility, known-allergy and self-access conditions still govern the program listing. Assess the complaint separately from selecting an OTC supply and use the clinical pathway when needed. No general pediatric or 9-1-1 authorization follows from the category. Until a specific current label is identified, the absence of a universal dose is intentional.

Source: Over the Counter (OTC) Medications.

Explore this guide

Related guides

OCEMS sources

See linked source for document dates and scope restrictions.
Source checked September 16, 2026.
Summary updated 2026-09-30.

SO-F-02Over the Counter (OTC) Medications ↗

This summary does not replace the complete policy, current system notices, or clinical judgment.

Independent OCMedic summary. Open cited source ↗ Sources, review limits & corrections

Browse the field reference

Back to top